Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Value of a Risk Prediction Tool (PERSARC) for Effective Treatment Decisions of Soft-tissue Sarcomas Patients

NCT05741944 is registered in ClinicalTrials.gov with Leiden University Medical Center as lead sponsor.

NCT NCT05741944
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05741944 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Value of a Risk Prediction Tool (PERSARC) for Effective Treatment Decisions of Soft-tissue Sarcomas Patients
Lead sponsor
Leiden University Medical Center
Phase
Not applicable
Overall status
Active, not recruiting
Start date
August 24, 2021
Completion date
August 29, 2025
Enrollment
120 (estimated)
Sites
7

Conditions

As the registry lists them; a condition with its own page is linked.

predictive cancer model, soft-tissue sarcoma